Data Safety Monitoring Board Guidance To Provide Rules For Halting Trials
This article was originally published in The Gray Sheet
Executive Summary
FDA's draft guidance on data safety monitoring boards (DSMBs) will address when clinical trials should be stopped for safety or efficacy reasons.